Effect of hepatitis B virus (HBV) surface-gene variability on markers of replication during treated human immunodeficiency virus-HBV infection in Western Africa
| dc.rights.license | open | en_US |
| dc.contributor.author | BOYD, A. | |
| dc.contributor.author | MOH, Desmorys Raoul | |
| dc.contributor.author | MAYLIN, S. | |
| dc.contributor.author | ABDOU CHEKARAOU, M. | |
| dc.contributor.author | MAHJOUB, N. | |
| hal.structure.identifier | Bordeaux population health [BPH] | |
| dc.contributor.author | GABILLARD, Delphine | |
| hal.structure.identifier | Bordeaux population health [BPH] | |
| dc.contributor.author | ANGLARET, Xavier | |
| dc.contributor.author | EHOLIE, S. P. | |
| hal.structure.identifier | Bordeaux population health [BPH] | |
| dc.contributor.author | DANEL, Christine | |
| dc.contributor.author | DELAUGERRE, C. | |
| dc.contributor.author | ZOULIM, F. | |
| dc.contributor.author | LACOMBE, K. | |
| dc.date.accessioned | 2020-06-03T12:08:17Z | |
| dc.date.available | 2020-06-03T12:08:17Z | |
| dc.date.issued | 2019 | |
| dc.identifier.issn | 1478-3231 (Electronic) 1478-3223 (Linking) | en_US |
| dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/7720 | |
| dc.description.abstractEn | BACKGROUND & AIMS: Replication markers exhibit substantial variation during chronic hepatitis B virus (HBV) infection, part of which can be explained by mutations on the surface (S) gene. We aimed to identify S-gene mutations possibly influencing the quantification of HBV replication markers (MUPIQH) in HBV genotype E infection, common to Western Africa. METHODS: 73 antiretroviral treatment (ART)-naive human immunodeficiency virus (HIV)-HBV co-infected patients from Cote d'Ivoire, initiating anti-HBV-containing ART, had available HBV S-gene sequences. S-gene MUPIQHs were screened at ART-initiation based on lower HBV-DNA or HBsAg quantification (qHBsAg) compared to wildtype. Their association with HBV virological response and qHBsAg slope during treatment was evaluated. RESULTS: Genotype E was predominant (95.9%). At ART-initiation, median HBV-DNA was 7.27 log10 copies/mL (IQR=5.26-8.33) and qHBsAg 4.08 log10 IU/mL (IQR=3.49-4.61). Twelve S-gene MUPIQHs were identified among 21 patients (28.8%): sS140L (n=4), sD144A (n=1), sS167L (n=2), sS174N (n=6), sP178Q (n=2), sG185L (n=2), sW191L (n=2), sP203Q/R (n=2), sS204N/I/R/K/T/G (n=7), sN207T (n=2), sF212C (n=1) and sV224A/Y (n=7). MUPIQHs at positions s185+s191+s224 and s178+s204 were within highly-covarying networks of S-gene mutations. Older age (p=0.02), elevated transaminases (p=0.03), and anti-hepatitis B "e" antibody-positive serology (p=0.009) were significantly associated with prevalent MUPIQHs at ART-initiation. During treatment, baseline MUPIQHs were not associated with time-to-undetectable HBV-DNA (p=0.7) and qHBsAg levels decreased at similar rates between those with versus without MUPIQHs (p=0.5). CONCLUSION: Several novel S-gene mutations were associated with reductions in replication markers among West African co-infected patients. These mutations, however, do not affect response during antiviral treatment. Their diagnostic and clinical consequences need clarification. This article is protected by copyright. All rights reserved. | |
| dc.language.iso | EN | en_US |
| dc.subject.en | IDLIC | |
| dc.title.en | Effect of hepatitis B virus (HBV) surface-gene variability on markers of replication during treated human immunodeficiency virus-HBV infection in Western Africa | |
| dc.title.alternative | Liver Int | en_US |
| dc.type | Article de revue | en_US |
| dc.identifier.doi | 10.1111/liv.13975 | en_US |
| dc.subject.hal | Sciences du Vivant [q-bio]/Santé publique et épidémiologie | en_US |
| dc.identifier.pubmed | 30257068 | en_US |
| bordeaux.journal | Liver international | en_US |
| bordeaux.page | 280-289 | en_US |
| bordeaux.volume | 39 | en_US |
| bordeaux.hal.laboratories | Bordeaux Population Health Research Center (BPH) - UMR 1219 | en_US |
| bordeaux.issue | 2 | en_US |
| bordeaux.institution | Université de Bordeaux | en_US |
| bordeaux.peerReviewed | oui | en_US |
| bordeaux.inpress | non | en_US |
| bordeaux.identifier.funderID | Agence Nationale de Recherches sur le Sida et les Hépatites Virales | en_US |
| hal.export | false | |
| bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Liver%20international&rft.date=2019&rft.volume=39&rft.issue=2&rft.spage=280-289&rft.epage=280-289&rft.eissn=1478-3231%20(Electronic)%201478-3223%20(Linking)&rft.issn=1478-3231%20(Electronic)%201478-3223%20(Linking)&rft.au=BOYD,%20A.&MOH,%20Desmorys%20Raoul&MAYLIN,%20S.&ABDOU%20CHEKARAOU,%20M.&MAHJOUB,%20N.&rft.genre=article |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||